Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Lotus Eye Hospital & Institute Ltd

Diversified Consumer Services | Small Cap

Lotus Eye Hospital & Institute Ltd Health Insights
Health Score : 6.07Health Score : 6.07

Lotus Eye Hospital & Institute Ltd demonstrates a mixed financial performance. The company shows strong solvency, indicating a healthy balance between debt and equity. Efficiency ratios highlight effective inventory and receivables management, but fixed asset and capital turnover need improvement. While revenue growth is positive, declines in operating profit, EPS, and net income growth raise concerns about long-term sustainability. The company's interest coverage is strong, but dividend coverage is weak. Profitability metrics, such as gross profit margin, ROCE, ROE, and operating margin, are robust, but ROA is just average. Overall, the company exhibits financial strengths in solvency, efficiency and profitability but needs to address weaknesses in growth and financial management to ensure sustained financial health.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Lotus Eye Hospital & Institute Ltd Health Insights
Health Score : 6.07Health Score : 6.07

Lotus Eye Hospital & Institute Ltd demonstrates a mixed financial performance. The company shows strong solvency, indicating a healthy balance between debt and equity. Efficiency ratios highlight effective inventory and receivables management, but fixed asset and capital turnover need improvement. While revenue growth is positive, declines in operating profit, EPS, and net income growth raise concerns about long-term sustainability. The company's interest coverage is strong, but dividend coverage is weak. Profitability metrics, such as gross profit margin, ROCE, ROE, and operating margin, are robust, but ROA is just average. Overall, the company exhibits financial strengths in solvency, efficiency and profitability but needs to address weaknesses in growth and financial management to ensure sustained financial health.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Overvalued

P/E RATIO (TTM)

369.59

Highly Overvalued

Industry Median

23.43

Highly Overvalued
Highly Overvalued

Small Cap Median

23.43

Highly Overvalued

P/E RATIO

328.53

P/B RATIO

4.05

Neutral

Industry Median

1.98

Neutral
Neutral

Small Cap Median

1.98

Neutral

P/S RATIO

4.96

Overvalued

Industry Median

2.99

Overvalued
Highly Overvalued

Small Cap Median

2.99

Highly Overvalued

Others

Highly Undervalued

PEG RATIO

-25.67

Highly Undervalued
Overvalued

EV/EBITDA RATIO

50.83

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹118.27 as on Jun 15, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.80

The company shows positive revenue and asset growth, but declines in operating profit, EPS, and net income growth are concerning. While revenue growth indicates expanding market presence, declining profitability metrics suggest rising costs or inefficiencies. Focus on cost management and operational efficiency is needed to translate revenue growth into improved profitability.

ExcellentRevenue Growth RateExcellent
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate20.2520.92.492.88.4
Operating Profit Growth Rate63.5429.73-13.67-46.3-5.06
Earnings Per Share (EPS) Growth90.6737.06-28.57-74.29-88.89
Asset Growth Rate4.022.565.464.4118.73
Net Income Growth Rate89.8136.91-28.68-74.57-89.19
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

The company's financial metrics present a mixed picture. While capital expenditures are well-managed, adjusted EPS, cash EPS, book value per share, and dividend per share are low. The careful management of capital expenditures is commendable, the poor performance in other financial metrics might be concerning. Efforts to improve profitability and shareholder value are needed.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)1.431.961.40.360.04
Cash Earnings Per Share (Cash EPS)2.633.393.191.81.84
Book Value Per Share26.2527.6828.5628.8528.91
Dividend Per Share (DPS)0.50.5000
Capital Expenditures (CapEx)4.73.15.54.812.9
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.60

The company demonstrates good profitability, with strong gross profit margin, ROCE, ROE, operating margin, and net margin. These ratios indicate effective cost management and pricing strategies. Above-average profitability enhances the company's ability to reinvest in growth initiatives. Maintaining these high profitability levels is essential for long-term financial health.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
AverageReturn on Assets (ROA)Average
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin8.799.996.021.11-0.69
Return on Capital Employed (ROCE)7.9110.257.072.991.16
Return on Equity (ROE)5.467.094.91.230.13
Return on Assets (ROA)9.6112.169.955.124.09
Operating Margin15.2216.3313.767.186.29
Net Margin7.668.686.041.490.15
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 7.33

The company demonstrates good efficiency in inventory and receivables management, but its fixed asset and capital turnover are low. Efficient inventory and receivables management ensures smooth operations and quick conversion of sales into cash. However, the company is not using its fixed assets or capital very efficiently. Addressing this could improve overall profitability and operational effectiveness.

PoorFixed Asset Turnover RatioPoor
ExcellentInventory Turnover RatioExcellent
ExcellentReceivables Turnover RatioExcellent
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio0.881.060.990.920.82
Inventory Turnover Ratio17.3516.615.113.9214.12
Receivables Turnover Ratio57.2152.5539.6738.4142.46
Days Sales in Inventory Ratio21.0421.9924.1726.2225.85
Receivable Days6.386.959.29.58.6
Capital Turnover Ratio0.70.810.80.780.72
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company has a strong interest coverage ratio but a weak equity dividend coverage ratio. The strong interest coverage ensures the company can easily meet its interest obligations. The low dividend coverage, however, indicates that the company is not using equity to pay dividends. Improving dividend coverage could enhance investor confidence.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio20.4829.2521.053.880.94
Equity Dividend Coverage Ratio2.873.92
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits strong solvency, with a low debt ratio and debt-to-equity ratio, coupled with a high equity ratio. This indicates a solid financial structure with minimal reliance on debt. The company's assets are largely financed by equity, providing a stable base for operations. The healthcare industry benefits from such stability, especially during economic downturns.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.020.010.020.050.2
Debt to Equity Ratio0.020.010.020.050.25
Equity Ratio0.980.990.980.950.8
Debt To Asset Ratio0.020.010.020.050.18
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, as indicated by the very low current, quick, and cash ratios. Because of the healthcare sector's reliance on consistent cash flow, this may cause some issues. The company's capacity to meet its short-term commitments may be hampered by its low liquidity ratios. This necessitates careful monitoring of cash flow and working capital, despite the industry's generally stable demand.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio3.053.852.932.522.12
Quick Ratio2.653.292.41.91.63
Cash Ratio1.541.711.150.680.49
Operating Cash Flow Ratio0.770.890.930.440.38
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 4 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Vaidya Sane Ayurved Laboratories Ltd7.7220.63Undervalued15.004.699.00
2Maitreya Medicare Ltd7.34-40.14Neutral-0.46-1.96-2.47
3Lotus Eye Hospital & Institute Ltd6.07328.53Overvalued3.380.040.08
4Nephro Care India Ltd5.6933.82Neutral8.322.043.37
Management Assessment Summary
OrangeBalanced Management

The management of Lotus Eye Hospital & Institute Ltd faces challenges in maintaining profitability and investor confidence. While the company has shown revenue growth, there are concerns about declining profit growth and a significant decrease in promoter holding. The management's effectiveness is assessed as mixed.

Category Metric Value Assessment
PROS Sales Growth (2014-2025) Positive Demonstrates consistent revenue growth.
CONS Compounded Profit Growth (TTM) -75% Indicates significant recent decline.
CONS Promoter Holding Change (Mar 2023 to Mar 2025) -17.95% Raises concerns about long-term strategic alignment.
CONS ROCE % (Mar 2025) 2.79% Shows low returns on capital.
AverageFinancial Performance & GrowthAverage
WeakCapital Efficiency & ReturnsWeak
AverageFinancial Health & PrudenceAverage
WeakShareholding & Ownership StructureWeak
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Lotus Eye Hospital & Institute Ltd is rated as Orange, indicating moderate risk. The primary concern is the segment performance volatility, evidenced by fluctuating quarterly sales and profit growth. The significant decrease in promoter holding increases risks associated with strategic direction and investor confidence. Working capital management is efficient. Overall, the company faces notable risks requiring careful monitoring.

AverageSegment performance volatilityAverage
WeakForeign exchange or interest rate exposureWeak
ExcellentWorking capital managementExcellent
GoodContingent liability evaluationGood
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Working capital management

04.

Contingent liability evaluation

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe